{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:08:48Z","timestamp":1780416528034,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["15042"],"award-info":[{"award-number":["15042"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["16686"],"award-info":[{"award-number":["16686"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013428","name":"Stichting Spieren voor Spieren","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007423","name":"Duchenne Parent Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Princess Beatrix Foundation for Neuromuscular Diseases","doi-asserted-by":"publisher","award":["W.OR11-11"],"award-info":[{"award-number":["W.OR11-11"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"Association fran\u00e7aise contre les myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nmd.2025.106255","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:30:27Z","timestamp":1761355827000},"page":"106255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antisense-mediated exon skipping therapy improves neuromuscular junction deficits in a Duchenne muscular dystrophy mouse model"],"prefix":"10.1016","volume":"56-57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8223-0131","authenticated-orcid":false,"given":"Elizabeth M.","family":"van der Pijl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Pasteuning-Vuhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Boertje-van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H.","family":"Niks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Plomp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"van Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.106255_bib0001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2025.106255_bib0002","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2025.106255_bib0003","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00001756-199210000-00009","article-title":"Different distributions of dystrophin and related proteins at nerve-muscle junctions","volume":"3","author":"Bewick","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.nmd.2025.106255_bib0004","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/ejn.13249","article-title":"Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models","volume":"43","author":"van der Pijl","year":"2016","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.nmd.2025.106255_bib0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nmd.2018.02.013","article-title":"Low dystrophin levels are insufficient to normalize the neuromuscular synaptic abnormalities of mdx mice","volume":"28","author":"van der Pijl","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.106255_bib0006","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004240100561","article-title":"Adult dystrophic (mdx) endplates exhibit reduced quantal size and enhanced quantal variation","volume":"442","author":"Carlson","year":"2001","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.nmd.2025.106255_bib0007","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/BF01187915","article-title":"Structure and function of the neuromuscular junction in young adult mdx mice","volume":"20","author":"Lyons","year":"1991","journal-title":"J Neurocytol"},{"key":"10.1016\/j.nmd.2025.106255_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205926","article-title":"Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy","volume":"13","author":"Haddix","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.106255_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135304","article-title":"Alterations of neuromuscular junctions in Duchenne muscular dystrophy","volume":"737","author":"Lovering","year":"2020","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nmd.2025.106255_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nmd.2025.106255_bib0011","first-page":"140","article-title":"The therapeutic potential of antisense-mediated exon skipping","volume":"10","author":"Van Ommen","year":"2008","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.nmd.2025.106255_bib0012","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/nat.2020.0845","article-title":"The 10th Oligonucleotide Therapy Approved: golodirsen for Duchenne Muscular Dystrophy","volume":"30","author":"Aartsma-Rus","year":"2020","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.nmd.2025.106255_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: the Next Chapter in the Eteplirsen Saga","volume":"27","author":"Aartsma-Rus","year":"2016","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.nmd.2025.106255_bib0014","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-020-01339-3","article-title":"Viltolarsen: first Approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.nmd.2025.106255_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nmd.2025.106255_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13543784.2021.1868434","article-title":"Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies","volume":"30","author":"Sheikh","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.nmd.2025.106255_bib0017","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41573-023-00775-6","article-title":"Therapeutic approaches for Duchenne muscular dystrophy","volume":"22","author":"Roberts","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nmd.2025.106255_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031937","article-title":"The effects of low levels of dystrophin on mouse muscle function and pathology","volume":"7","author":"van Putten","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.106255_bib0019","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jcsm.12506","article-title":"Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology","volume":"11","author":"van Westering","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nmd.2025.106255_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mcn.2008.12.011","article-title":"Truncated dystrophins can influence neuromuscular synapse structure","volume":"40","author":"Banks","year":"2009","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nmd.2025.106255_bib0021","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jgm.295","article-title":"Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy","volume":"4","author":"Mann","year":"2002","journal-title":"J Gene Med"},{"key":"10.1016\/j.nmd.2025.106255_bib0022","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1113\/jphysiol.1981.sp013586","article-title":"Non-linear summation of end-plate potentials in the frog and mouse","volume":"311","author":"McLachlan","year":"1981","journal-title":"J Physiol"},{"key":"10.1016\/j.nmd.2025.106255_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JND-150126","article-title":"Accurate Dystrophin Quantification in Mouse Tissue; Identification of New and Evaluation of Existing Methods","volume":"3","author":"Hulsker","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.106255_bib0024","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41582-018-0033-8","article-title":"Why dystrophin quantification is key in the eteplirsen saga","volume":"14","author":"Aartsma-Rus","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nmd.2025.106255_bib0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.nmd.2025.106255_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2015.00252","article-title":"Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice","volume":"6","author":"Pratt","year":"2015","journal-title":"Front Physiol"},{"key":"10.1016\/j.nmd.2025.106255_bib0027","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1113\/jphysiol.2012.241679","article-title":"Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles","volume":"591","author":"Pratt","year":"2013","journal-title":"J Physiol"},{"key":"10.1016\/j.nmd.2025.106255_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep24849","article-title":"Age-related fragmentation of the motor endplate is not associated with impaired neuromuscular transmission in the mouse diaphragm","volume":"6","author":"Willadt","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2025.106255_bib0029","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1093\/nar\/gkac018","article-title":"Control of backbone chemistry and chirality boost oligonucleotide splice switching activity","volume":"50","author":"Kandasamy","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2025.106255_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jgm.1288","article-title":"In vivo comparison of 2\u2019-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping","volume":"11","author":"Heemskerk","year":"2009","journal-title":"J Gene Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625009824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625009824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:04:11Z","timestamp":1766059451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625009824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S0960896625009824"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106255","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense-mediated exon skipping therapy improves neuromuscular junction deficits in a Duchenne muscular dystrophy mouse model","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106255"}}